Pfizer R&D head sees more drug collaborations
NEW YORK (Reuters) - Pfizer Inc's research chief said he foresees more collaborations with other pharmaceutical companies in an effort to share the cost and risk of drug development and potentially get more experimental medicines into expensive late stage testing.
<p>You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~a/reuters/healthNews?i=M00V5I" border="0)
</img>
</p><div class="feedflare">
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=zgkyL" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=JInQl" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=aobMl" border="0)
</img>
</div>
![](http://feeds.reuters.com/~r/reuters/healthNews/~4/402210749" height="1" width="1)
You are not allowed to view links.
Register or
Login
